Abacavir and Lamivudine Tablets and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Abacavir and Lamivudine Tablets and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / lamivudine
Brand name: Epzicom
Synonyms: Abacavir and lamivudine
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir and Lamivudine Tablets-Kitabis Pak
- Abacavir and Lamivudine Tablets-Kitabis Pak inhalation
- Abacavir and Lamivudine Tablets-Klofensaid II
- Abacavir and Lamivudine Tablets-Klonopin
- Abacavir and Lamivudine Tablets-Klonopin Wafer
- Abacavir and Lamivudine Tablets-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir Oral Solution
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir Sulfate
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir Sulfate Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir Tablets
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir, dolutegravir, and lamivudine
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Abacavir, Lamivudine and Zidovudine Tablets